跳至主要内容
临床试验/NCT00867789
NCT00867789终止不适用

Trimethoprim-sulfamethoxazole Versus Placebo in the Treatment of Cutaneous Abscesses in the Emergency Department

Children's Mercy Hospital Kansas City1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2009年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
发起方
入组人数
140
试验地点
1
主要终点
Health Outcomes After Use With Trimethoprim-sulfamethaxazole

研究概览

简要总结

The purpose of this study is to determine if there is a difference between an antibiotic, trimethoprim-sulfamethoxazole versus placebo in healing outcomes of soft tissue abscesses following incision and drainage.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
3 Months 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Age 3 months to 17 years
  • Single, localized soft tissue abscesses requiring incision and drainage with purulent material obtained
  • Diameter of the abscess less than 5cm as measured by the treating physician

排除标准

  • Signs of systemic illness or ill-appearing, as determined by the treating physician
  • Admission to the hospital following treatment in the Emergency Department
  • Known sulfa allergy
  • Immunocompromised patients
  • Soft tissue abscesses involving the perineum (labia, scrotum, penis, perirectal)
  • Previous antibiotic use (for any reason) in the past seven days
  • Non-English speaking patients and families

研究组 & 干预措施

Trimethoprim-sulfamethaxazole

Experimental

Incision and drainage of the abscess and treatment with oral TMP-SMX (100 patients)

干预措施: Trimethoprim-sulfamethoxazole (Drug)

Sugar pill

Placebo Comparator

Incision and drainage of the abscess and treatment with oral placebo (100 patients)

干预措施: Sugar pill (Drug)

结局指标

主要结局

Health Outcomes After Use With Trimethoprim-sulfamethaxazole

时间窗: two years

次要结局

未报告次要终点

研究者

发起方
Children's Mercy Hospital Kansas City
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验